Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
memantine (namenda) (1 trial)
Anxiety Disorders (Phase 3)
Compulsive Personality Disorder (Phase 3)
Disease (Phase 3)
Obsessive-Compulsive Disorder (Phase 3)
Trials (1 total)
Trial APIs (1 total)